Xenetic Biosciences XBIO
NASDAQ XBIO
$1.93 -0.05 (-2.53%)
At close: Oct 22, 2026 · 4:00 PM EDT

Xenetic Biosciences (XBIO) Long-Term Debt Issuances (2013 - 2016)

Updated

Xenetic Biosciences (XBIO) reported Long-Term Debt Issuances of $4.5 million for FY2016, up 45.2% from $3.1 million in FY2015.

Analysis

Xenetic Biosciences (XBIO) Long-Term Debt Issuances (2013 - 2016) Analysis & Trends

Dating back to FY2011, Xenetic Biosciences' Long-Term Debt Issuances record includes 4 years.

  • Long-Term Debt Issuances has a five-year compound annual growth rate of 84.1% (FY2011 to FY2016).
  • According to Business Quant data, Long-Term Debt Issuances came in at $3.1 million in FY2015 and $212,813 in FY2012 (unchanged).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Xenetic Biosciences 4.52 Mn -21.30 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 1.00 Mn
Mar 31, 2016 3.50 Mn
Sep 30, 2015 3.00 Mn
Jun 30, 2015 100,000.00
Nov 30, 2013 160,000.00
API Access

Xenetic Biosciences Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=XBIO&period=max&api_key=YOUR_API_KEY